Better Access Better Healthcare
We improve global healthcare through better access to medicine.
Abacus Medicine is firmly established among the market leaders in the European parallel distribution industry.
Originalis is a parallel distributor of medicine operating in Germany and Ireland.
Abacus Medicine Pharma Services works with Clinical Trial Supply, Commercial Partnerships and Unlicensed Medicines.
Pluripharm is a leading wholesaler in the Netherlands and offers a full line of medicines, medical devices and services to a range of customers.
We are innovative, dedicated
and we care.
The Abacus Medicine Group is built on a strong purpose. When we compete in the market, we help lower the prices on life-critical medicines so that they become more widely available.
The Abacus Medicine Group is a business. We operate commercially, and our activities provide jobs, careers and livelihoods for hundreds of people in dozens of countries.
But we are more than that. When we compete in the market, we help life-critical medicines become more widely available. This gives us a purpose beyond ourselves and is something we can be proud of.
Flemming Wagner
CEO & majority shareholder
Global locations
Employees
Packs sold in 2022
A career in the Abacus Medicine Group
Join an ambitious and diverse company.
We are always looking for new and dedicated colleagues.
Latest news
Sustainability Report 2022: The Abacus Medicine Group continued to work with sustainability and ESG within 6 focus programs
A materiality assessment, an official Diversity & Inclusion strategy, and workshops for increased awareness of sustainability and ESG across the company were among the concrete initiatives in the Group’s strategic sustainability efforts.
Annual Report 2022: Profitability focus pays off for the Abacus Medicine Group
Increasing profitability was a declared target for the Group for 2022 and this was successfully achieved. Based on strong performance especially in the parallel distribution business EBITDA grew 58% to a record level of EUR 26.2 million.
Milestone: 1,000,000,000 euros
The Abacus Medicine Group has reached another major milestone. Today, the combined revenue of the group’s business units has surpassed 1,000,000,000 euros for the first time.